|
|
|
|
|
|
| Jamie Macdonald to share key industry insights on clinical innovation and alliance partnerships |
Raleigh, N.C., Mar 28, 2014 - (ACN Newswire) - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced it will feature three senior leaders, including CEO Jamie Macdonald, at this year's Partnerships in Clinical Trials conference, March 30 - April 2, 2014 in Las Vegas. Macdonald, along with Senior Vice President, Clinical Innovation John Whitaker and Senior Vice President, Global Consulting Jane Winter, will lead discussions on a range of topics, including alliance partnerships, clinical innovation and risk-based monitoring.
"The Partnerships conference provides a great opportunity to explore new approaches in clinical outsourcing with other industry thought leaders," said INC Research CEO Jamie Macdonald. "This year, I'm thrilled to be taking part in a panel examining the state of the clinical outsourcing industry. As the lone CRO representative on the panel, I look forward to serving as an ambassador for our industry in exchanging perspectives with biopharmaceutical leaders on how innovative alliance partnerships, along with leading-edge technologies and monitoring strategies, can promote progress toward more intelligent, data-driven approaches to clinical trial design and execution."
INC Research Thought Leaders at Partnerships
-- In addition to the panel, Macdonald will participate in the 2nd Annual Executive Leadership Boardroom: Shifting the Drug Development Model & Moving Toward a Real Partnership, an idea exchange and leadership forum for pharma, biotech, medical device and CRO executives. Macdonald, along with other invited CRO leaders, will exchange ideas, insights and new ways to partner at this invitation-only event, which takes place Monday, March 31 from 10 a.m. to 4 p.m.
-- Jane Winter, Senior Vice President, Global Consulting, will present "The Rules of Engagement: Building a Collaborative Environment" on Monday, March 31 at 2 p.m. as part of the "Fundamentals of Clinical Outsourcing Certificate Program" hosted in conjunction with the Partnerships in Clinical Trials conference. This hands-on workshop will offer a real-world approach to evaluating the health of outsourcing relationships, while highlighting the importance of building a robust governance model when entering into such arrangements.
-- John Whitaker, PhD, Senior Vice President, Clinical Innovation, will participate in an interactive panel discussion on "The Tactical Approach to Disruptive Innovation in Clinical Trials," taking place Tuesday, April 1 from 4 - 5 p.m. (Track B). Panelists will discuss how to implement innovative strategies to reduce cost and development time.
-- As mentioned previously, Macdonald is a featured panelist on the Avoca panel discussion, "The State of Clinical Outsourcing: The Impact of Outsourcing Partnerships on Clinical Trial Optimization," taking place Wednesday, April 2 at 11:45 a.m. (Track F). The panel will explore best practices for using outsourcing relationships to promote "intelligent" approaches in clinical development.
INC Research is at the forefront of a transformation in the existing clinical development model in which sponsors and CROs are working together to create a new paradigm where both parties serve as true partners with shared goals to form alliance partnerships. INC Research focuses exclusively on Phase I through Phase IV clinical trials, a sharp focus that allows us to offer fine-tuned strategic expertise in pipeline management, registration strategies, compliance and other aspects of the drug development and commercialization continuum. For more information on our strategic alliance capabilities, click here. http://bit.ly/1dRV056
For additional background or to schedule a meeting with an INC Research representative at Partnerships in Clinical Trials, visit the INC Research site or stop by booth #703 at the conference.
About INC Research
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest quality. Pharmaceutical and biotechnology companies look to us for a complete range of customized Phase I to IV programs in all therapeutic areas and patient populations. Our Trusted Process(R) methodology and therapeutic foresight lead customers to better-informed product development decisions, while our solid site relationships are a critical success factor in delivering clinical trial results on time and on budget. INC was ranked "Top CRO" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.
Contact:
Bill Wherle, Media +1-513-763-1442
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Globenewswire
Topic: Research and development
Source: INC Research, LLC
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
|
